COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 21 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,671,963 | -30.0% | 300,173 | +2.5% | 0.14% | -17.3% |
| Q2 2023 | $2,388,619 | +17.4% | 292,723 | +1.0% | 0.17% | +16.9% |
| Q1 2023 | $2,034,374 | +84771.7% | 289,797 | +0.9% | 0.15% | -20.9% |
| Q4 2022 | $2,397 | -99.9% | 287,147 | +0.3% | 0.19% | +20.6% |
| Q3 2022 | $1,946,000 | -8.9% | 286,197 | +7.2% | 0.16% | -3.1% |
| Q2 2022 | $2,135,000 | -28.5% | 266,897 | +0.3% | 0.16% | -9.6% |
| Q1 2022 | $2,984,000 | -29.0% | 265,997 | +3.6% | 0.18% | -26.6% |
| Q4 2021 | $4,202,000 | +0.2% | 256,872 | +3.5% | 0.24% | -1.2% |
| Q3 2021 | $4,193,000 | -20.0% | 248,150 | +0.4% | 0.24% | -13.2% |
| Q2 2021 | $5,244,000 | – | 247,250 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 577,909 | $3,253,628 | 6.54% |
| VILLERE ST DENIS J & CO LLC | 300,173 | $1,671,963 | 0.14% |
| PINNACLE ASSOCIATES LTD | 478,309 | $2,664,181 | 0.05% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 45,050 | $254 | 0.01% |
| FNY Investment Advisers, LLC | 1,539 | $8 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,140 | $130,278 | 0.00% |
| BROWN ADVISORY INC | 74,836 | $416,837 | 0.00% |
| Geneos Wealth Management Inc. | 750 | $4,223 | 0.00% |
| Focused Wealth Management, Inc | 242 | $1,348 | 0.00% |
| UBS Group AG | 5,690 | $31,693 | 0.00% |